Medicxi Ventures Management (Jersey) LTD Rapt Therapeutics, Inc. Transaction History
Medicxi Ventures Management (Jersey) LTD
- $455 Million
- Q4 2024
A detailed history of Medicxi Ventures Management (Jersey) LTD transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Medicxi Ventures Management (Jersey) LTD holds 22,352,000 shares of RAPT stock, worth $27.3 Million. This represents 7.76% of its overall portfolio holdings.
Number of Shares
22,352,000Holding current value
$27.3 Million% of portfolio
7.76%Shares
1 transactions
Others Institutions Holding RAPT
# of Institutions
105Shares Held
27.1MCall Options Held
26.7KPut Options Held
2.4K-
Vanguard Group Inc Valley Forge, PA3.16MShares$3.85 Million0.0% of portfolio
-
Column Group LLC San Francisco, CA2.68MShares$3.27 Million7.75% of portfolio
-
Black Rock Inc. New York, NY2.44MShares$2.98 Million0.0% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY1.73MShares$2.1 Million0.42% of portfolio
-
Ponoi Management, LLC San Francisco, CA1.6MShares$1.95 Million52.54% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $36.2M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...